A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, London, has shown.

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test, a new study reports.

A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.